A Case of Hepatitis B Reactivation with Acute Flare Three Months After Tenofovir Prophylaxis Withdrawal in a Allogenic Hematopoietic Stem Cell Transplantation Patient
Journal Title: Viral Hepatitis Journal - Year 2018, Vol 24, Issue 2
Abstract
Hepatitis B virus (HBV) infection is a major health problem worldwide. HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and, prophylactic antiviral treatment is suggested to prevent this phenomenon. However, the duration of antiviral treatment in HSCT patients is not fully defined and the time of immune recovery is considered the best parameter for a drug to be safely interrupted. We aimed to present a case of hepatitis B reactivation after cessation of one-year prophylactic tenofovir treatment in a anti-hepatitis B core immunoglobulin G-positive patient who received allogenic HSCT treatment for chronic lymphocytic leukemia.
Authors and Affiliations
Bilal TOKA, Ahmet Tarık EMİNLER, Ferhat Gürkan ASLAN, Aydın Şeref KÖKSAL, Mustafa ALTINDİŞ
Keywords
Related Articles
- EP ID EP382509
- DOI 10.4274/vhd.2018.0001
- Views 83
- Downloads 0
Two Rare Causes of Hepatitis: Fascioliasis and Brucellosis
Brucellosis and fascioliasis are zoonoses which induce different type of cell-mediated immune responses and rarely cause hepatitis with together. Brucellosis induces T helper type 1 (Th1) immune response whereas Fasciola...
Sixteen-year Prognosis of Treatment-naive Patients with Hepatitis C Infection
Objectives: In this study, we aimed to evaluate the clinical course of treatment-naive patients infected with hepatitis C virus (HCV) who were followed up in various centers in Turkey. Materials and Methods: This was a r...
Evaluation of Hepatitis C Virus Genotype Results in İzmir Atatürk Training and Research Hospital
Objectives: The aim was to support both the clinical treatment and management and also to contribute to the epidemiological understanding of the hepatitis C virüs (HCV) genotype in our region. Materials and Methods: HCV...
The Importance of Antiviral Prophylaxis against Hepatitis B Virus in Patients under Immunosuppressive Therapy
Objectives: Immunosuppressive (IS) therapies present a risk of reactivation in patients with previous or known hepatitis B virus (HBV) infection and may cause mortality and morbidity. Before starting these therapies, pat...
Interleukin 28B rs12979860 CT, rs12980275 GA, rs8099917 GT and TT genotypes are the Predictors of Rapid Viral Response in Hepatitis C Virus-Infected Patients
Objective: In this study, the effects of genotypic differences on the clinical course of the disease, response to treatment and fibrosis were investigated in patients with hepatitis C virus (HCV) infection. Materials and...